Form 4 for AXGN Axogen, Inc.
Accepted 2021-07-21 00:00:00 ET · period of report 2021-07-19 · accession 0000805928-21-000148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-21 | 2021-07-19 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | A - Grant | $0.00 | +1,580 | 80.8K | +2% | $0 | |
| 2021-07-21 | 2021-07-20 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $19.20 | -392 | 80.4K | -0.5% | -$7,526 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-19 | A | A | 1,580 | $0.00 | 80,818 | D | — | — | (F1) This reflects the number of shares that became vested as of July 19, 2021 upon the attainment of certain performance criteria. |
| 2 | Common | Common Stock | 2021-07-20 | F | D | 392 | $19.20 | 80,426 | D | — | — | (F2) The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on July 19, 2021. |